BMMs isolated from Atg16L1E230+ and Atg16L1E230– animals engrafted with AML were therefore examined for STING activation by measuring Gbp2, Irf7, and Ifit3 gene expression (Figure 4A and refs. 35, 43). The gene discussed is GBP2; the disease is acute myeloid leukemia.